As part of Global Polio Endgame strategy, India has reached another milestone by launching Inactivated Polio Vaccine (IPV) today. This vaccine has been introduced to prevent re-emergence of polio.
Injectable Inactivated Polio Vaccine (IPV) will be introduced in the ongoing Universal Immunisation Programme (UIP) simultaneously with the existing Oral Polio Vaccine (OPV). IPV launch is a giant leap in India's public health program. In the first phase, the injection will be introduced in six states: Assam, Bihar, Uttar Pradesh, Gujarat, Madhya Pradesh and Punjab.
The main aim behind this ambitious programme is to strengthen the children’s immune system and to provide double protection against polio. IPV injection will be given to children below one year of age along with the third dose of the Oral Polio Vaccine, at about 3 ½ months in addition to the existing doses of OPV. This vaccine is available free of cost. Until polio is eradicated globally, OPV is still the main preventive measure against polio. Thus, IPV is recommended in addition to OPV and does not replace OPV. According to WHO data, the IPV can be administered in combination with other vaccines (e.g. diphtheria, tetanus, pertussis, hepatitis B, and haemophilus influenza).
IPV is administered by intramuscular (IM) injection that is safe and very well-tolerated. Severe adverse reactions are rare. Redness, swelling and soreness might appear in some cases but eventually subsides; fever may happen in some cases.
Q-1What is IPV?
Inactivated Polio Vaccine (IPV) is an injectable form of polio vaccine which can be administered alone or in combination with other vaccines like OPV (oral polio vaccine), diphtheria, tetanus, pertussis, hepatitis B, and haemophilus influenza.
Q-2 What are the Contraindications for IPV?
There are two contraindications for IPV:
If anyone has a history of an allergic reaction
If any infants with known allergy to streptomycin, neomycin, or polymyxin B because they all are inactive components for IPV
Q-3 Is IPV safe for premature Infants?
Yes, IPV is safe for premature infants.
Q-4 Is IPV useful for immune deficient population?
Yes, it is safe. IPV can be safely administered to children with immune deficiencies (e.g., HIV, congenital or acquired immunodeficiency, sickle cell disease). In fact, because of the elevated risk of vaccine-associated paralytic polio after the use of OPV in patients with immune deficiencies, IPV is universally recommended in these children.